Holen Sie sich die Stockscreener-App
352.66
0.76%
2.5005
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$350.16
Offen:
$350.2
24-Stunden-Volumen:
171.14K
Relative Volume:
0.06
Marktkapitalisierung:
$124.48B
Einnahmen:
$11.03B
Nettoeinkommen (Verlust:
$3.16B
KGV:
40.42
EPS:
8.7251
Netto-Cashflow:
$3.22B
1W Leistung:
-5.13%
1M Leistung:
-6.86%
6M Leistung:
-28.52%
1J Leistung:
-24.54%
1-Tages-Spanne:
$349.86
$357.99
1-Wochen-Bereich:
$347.52
$378.99
52-Wochen-Spanne:
$328.57
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
352.37 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
177.66 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
68.86 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
217.36 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.15 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Intuitive Surgical stock heads into the open after a 4.5% drop - AD HOC NEWS
Here's Why Intuitive Surgical, Inc. (ISRG) Fell More Than Broader Market - Yahoo Finance
Is Intuitive Surgical Inc (ISRG) a Bargain After 4.5% Drop? GF V - GuruFocus
Intuitive Surgical Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com
Intuitive Surgical (ISRG) officer to sell 694 shares - Stock Titan
Intuitive study finds da Vinci surgery linked to shorter stays By Investing.com - Investing.com Canada
A review of 14 million surgeries links robot-assisted surgery to faster recovery - Stock Titan
(ISRG) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.38% on Sep 8: Drivers Behind the Movement - TradingKey
Intuitive Surgical Stock (ISRG) Opinions on Q2 Earnings and Procedure Slowdown - Quiver Quantitative
Why Intuitive Surgical (ISRG) Stock Is Down Today - Moomoo
Intuitive Surgical stock gains support as BTIG reiterates buy rating and strong Q2 2026 growth - AD HOC NEWS
The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT - Zacks Investment Research
ISRG Reiterated by BTIG -- Rating Maintained at Buy - GuruFocus
Intuitive Surgical stock heads into the open after a 2.9% drop - AD HOC NEWS
Formuepleje A S Has $1.33 Million Stake in Intuitive Surgical, Inc. $ISRG - InsuranceNewsNet
ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine - TradingView
Intuitive Surgical stock steadies after strong Q2 earnings beat - AD HOC NEWS
Intuitive Surgical (ISRG): Embracing AI Innovations in Robotic Surgery for Future Growth - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30% Upside Potential Beckons Investors - DirectorsTalk Interviews
Why Is ISRG in Focus Across the Nasdaq Composite This Week? - Kalkine Media
Intuitive Surgical stock heads into the open after a 2.9% slide - AD HOC NEWS
Intuitive Surgical (ISRG) Down 30% This Year; Can Tonight’s Q2 Earnings Reverse the Bearish Channel? - tradingkey.com
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning? - The Globe and Mail
Intuitive Surgical stock gains on strong Q2 2026 margins and recurring revenue - AD HOC NEWS
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money - Yahoo Finance
Intuitive Surgical stock steadies ahead of Q2 2026 earnings report - AD HOC NEWS
SS Innovations International (NASDAQ: SSII) Highlighted as Stronger Growth Opportunity in Seeking Alpha Analysis - TradingView
How India built a new model for robotic surgery: Insights from Dr. Mahendra Bhandari and Siddharth Siva - The American Bazaar
Medtronic Tops Earnings Estimates and Makes $700M Robot Surgeon Investment. Is It Gaining on Intuitive Surgical? - Barron's
What Is Shaping Interest in Intuitive Surgical? (NASDAQ:ISRG) - Kalkine Media
How Is Intuitive Surgical's Stock Performance Compared to Other Health Care Equipment Stocks? - Barchart.com
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds? - TradingView
Intuitive Surgical stock trades well below its 52-week high as Q2 2026 growth supports da Vinci outl - AD HOC NEWS
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical Vs. SS Innovations: Why You Should Buy The Lesser-Known Indian Competitor - Seeking Alpha
Intuitive Surgical (ISRG) Q2 2026 Earnings Call Transcript - Fortune
Intuitive Surgical stock holds at $372 as da Vinci platform expands in robotic surgery - AD HOC NEWS
Intuitive Surgical (ISRG) Q1 2026 Earnings Call Transcript - Fortune
Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Closer Look At Its 28.29% Potential Upside - DirectorsTalk Interviews
Intuitive Surgical (ISRG) Pours Record Cash Flow Into 100 Plus Da Vinci 5 Upgrades - Sahm
Intuitive Surgical's Record Cash Flow Gives It an Innovation Advantage - TradingView
ISRG vs. MDT: Which Surgical Robot Stock Is the Smarter Buy? - TradingView
Intuitive - Forbes
Intuitive Surgical Inc. stock underperforms Monday when compared to competitors - marketwatch.com
Thermo Fisher vs. Intuitive Surgical: Which Premium Healthcare Stock Deserves its Valuation? - Yahoo Finance
How Slowing US Bariatric Procedures and Capital Constraints Will Impact Intuitive Surgical (ISRG) Investors - Yahoo Finance UK
Intuitive surgical EVP Mark Brosius sells $59,439 in stock - Investing.com
Intuitive surgical EVP Mark Brosius sells $59,439 in stock By Investing.com - Investing.com Canada
Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock - MarketBeat
Intuitive Surgical (NASDAQ: ISRG) EVP sells under 10b5-1 plan - Stock Titan
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.15%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):